Eli Lilly & Co.’s blockbuster obesity shot Zepbound helped people with type 1 diabetes lose more than a fifth of their body ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis.

Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound) ...

A recent announcement by Eli Lilly suggests that the company understands the economic conundrum some patients face. Per a ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the ...

Although women lost more weight, all participants saw significant decreases in total body weight on all doses of the medication.

The weight management drug Zepbound will now be sold in lower-cost vials in addition to preloaded injector pens, according to ...

Results from 4 studies revealed that women lost more weight on average than men when taking tirzepatide — but they also ...

Eli Lilly's weight loss treatment Zepbound might be a blockbuster in the making, but it wasn't without its challenges. See ...

Millions turn to compounded versions of popular weight loss drugs amid shortages and high costs.

Folks taking weight-loss drugs like Wegovy or Zepbound might think they've found a shortcut to better health. But they still ...

People who are in need of weight loss medications but do not have insurance coverage will soon have a new way to access one ...